16.10.2012
•
News
KSB’s X Lege No.2/2012
The main topics covered in the latest issue of X Lege include the digital dividend auction launched in mid-July by the Czech Telecommunications Authority and the new Supported Energy Sources Act. Starting in 2013, the act will supersede the current Renewable Energy Sources Act as well as the parts of the energy Act concerning secondary energy sources, cogeneration of electricity and heat, and decentralized power generation. As always, we also provide the latest news on the civil and commercial law recodification process: this issue includes the most substantial impacts holding companies can expect in 2014. There is also a summary related to EU law and information on the anti-discrimination amendment pertaining to the insurance industry.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
